Takeda makes fourth offer to buy Shire
23-04-2018
Shire to sell oncology business for $2.4bn
17-04-2018
Shire welcomes Adderall generic ruling
27-03-2018
Takeda makes waves with neurological collaboration
23-02-2018
designer491 / iStockphoto.com
Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Takeda, Shire, mergers and acquisitions, therapeutics, rare disease, M&A
